相似文献
1
Use of data mining at the Food and Drug Administration.
J Am Med Inform Assoc. 2016 Mar;23(2):428-34. doi: 10.1093/jamia/ocv063. Epub 2015 Jul 23.
2
Review of FDA Amendments Act Section 921 Experience in Posting Data-mining Results from the FAERS Database.
Clin Ther. 2021 Feb;43(2):380-395. doi: 10.1016/j.clinthera.2020.12.011. Epub 2021 Jan 24.
3
Prospective data mining of six products in the US FDA Adverse Event Reporting System: disposition of events identified and impact on product safety profiles.
Drug Saf. 2010 Feb 1;33(2):139-46. doi: 10.2165/11319000-000000000-00000.
4
A post-marketing pharmacovigilance study of avapritinib: Adverse event data mining and analysis based on the United States Food and Drug Administration Adverse Event Reporting System database.
Br J Clin Pharmacol. 2024 Aug;90(8):1816-1826. doi: 10.1111/bcp.15673. Epub 2023 Feb 6.
5
Post-marketing pharmacovigilance study of inclisiran: mining and analyzing adverse event data from the FDA Adverse Event Reporting System database.
Int J Clin Pharm. 2024 Dec;46(6):1419-1426. doi: 10.1007/s11096-024-01784-0. Epub 2024 Aug 27.
6
The FDA's sentinel initiative--A comprehensive approach to medical product surveillance.
Clin Pharmacol Ther. 2016 Mar;99(3):265-8. doi: 10.1002/cpt.320. Epub 2016 Jan 12.
7
Can Disproportionality Analysis of Post-marketing Case Reports be Used for Comparison of Drug Safety Profiles?
Clin Drug Investig. 2017 May;37(5):415-422. doi: 10.1007/s40261-017-0503-6.
8
A Postmarketing Pharmacovigilance Study of Fenfluramine: Adverse Event Data Mining and Analysis Based on the US Food and Drug Administration Public Data Open Project (openFDA).
Pediatr Neurol. 2025 May;166:96-102. doi: 10.1016/j.pediatrneurol.2025.03.001. Epub 2025 Mar 8.
9
OpenVigil FDA - Inspection of U.S. American Adverse Drug Events Pharmacovigilance Data and Novel Clinical Applications.
PLoS One. 2016 Jun 21;11(6):e0157753. doi: 10.1371/journal.pone.0157753. eCollection 2016.
10
Influence of the MedDRA hierarchy on pharmacovigilance data mining results.
Int J Med Inform. 2009 Dec;78(12):e97-e103. doi: 10.1016/j.ijmedinf.2009.01.001. Epub 2009 Feb 18.
引用本文的文献
1
Cancer related adverse events associated with use of proton pump inhibitors and histamine-2 receptor antagonists: A real-world analysis using the FDA adverse event reporting system.
PLoS One. 2025 Aug 12;20(8):e0329385. doi: 10.1371/journal.pone.0329385. eCollection 2025.
2
Drug-induced sinusoidal obstruction syndrome: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System (FEARS).
BMC Pharmacol Toxicol. 2025 Jul 18;26(1):135. doi: 10.1186/s40360-025-00965-5.
3
Hepatotoxicity associated with statins: A retrospective pharmacovigilance study based on the FAERS database.
PLoS One. 2025 Jul 9;20(7):e0327500. doi: 10.1371/journal.pone.0327500. eCollection 2025.
4
Cardiovascular toxicities associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a pharmacovigilance study based on FDA adverse event reporting system.
Int J Clin Pharm. 2025 Jul 2. doi: 10.1007/s11096-025-01962-8.
5
Risk comparison of adverse reactions between gemcitabine monotherapy and gemcitabine combined with albumin-bound paclitaxel in pancreatic cancer: insights from the FDA Adverse Event Reporting System (FAERS) database.
BMC Pharmacol Toxicol. 2025 Mar 19;26(1):65. doi: 10.1186/s40360-025-00884-5.
6
Drug-induced autoimmune-like hepatitis: A disproportionality analysis based on the FAERS database.
PLoS One. 2025 Feb 6;20(2):e0317680. doi: 10.1371/journal.pone.0317680. eCollection 2025.
7
Drug-induced dementia: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database.
Ther Adv Neurol Disord. 2025 Jan 28;18:17562864251315137. doi: 10.1177/17562864251315137. eCollection 2025.
8
Data mining in FAERS: association of newer-generation H1-antihistamines with nervous system disorders.
BMC Pharmacol Toxicol. 2024 Dec 18;25(1):95. doi: 10.1186/s40360-024-00822-x.
9
Quantitative Structure-Activity Relationship Models to Predict Cardiac Adverse Effects.
Chem Res Toxicol. 2024 Dec 16;37(12):1924-1933. doi: 10.1021/acs.chemrestox.4c00186. Epub 2024 Nov 13.
10
Drug-associated congenital anomalies of the external ear identified in the United States food and drug administration adverse event reporting system database.
Sci Rep. 2024 Oct 9;14(1):23624. doi: 10.1038/s41598-024-74744-3.
本文引用的文献
1
Indexed Pain Journals.
J Pain Palliat Care Pharmacother. 2008;22(1):45-46. doi: 10.1080/15360280801989377.
2
Novel algorithms for improved pattern recognition using the US FDA Adverse Event Network Analyzer.
Stud Health Technol Inform. 2014;205:1178-82.
3
Transforming health care delivery through consumer engagement, health data transparency, and patient-generated health information.
Yearb Med Inform. 2014 Aug 15;9(1):170-6. doi: 10.15265/IY-2014-0017.
4
Digital drug safety surveillance: monitoring pharmaceutical products in twitter.
Drug Saf. 2014 May;37(5):343-50. doi: 10.1007/s40264-014-0155-x.
5
Toward enhanced pharmacovigilance using patient-generated data on the internet.
Clin Pharmacol Ther. 2014 Aug;96(2):239-46. doi: 10.1038/clpt.2014.77. Epub 2014 Apr 8.
6
Automating case definitions using literature-based reasoning.
Appl Clin Inform. 2013 Oct 30;4(4):515-27. doi: 10.4338/ACI-2013-04-RA-0028. eCollection 2013.
7
Data mining for prospective early detection of safety signals in the Vaccine Adverse Event Reporting System (VAERS): a case study of febrile seizures after a 2010-2011 seasonal influenza virus vaccine.
Drug Saf. 2013 Jul;36(7):547-56. doi: 10.1007/s40264-013-0051-9.
8
Vaccine adverse event text mining system for extracting features from vaccine safety reports.
J Am Med Inform Assoc. 2012 Nov-Dec;19(6):1011-8. doi: 10.1136/amiajnl-2012-000881. Epub 2012 Aug 25.
9
Application of change point analysis to daily influenza-like illness emergency department visits.
J Am Med Inform Assoc. 2012 Nov-Dec;19(6):1075-81. doi: 10.1136/amiajnl-2011-000793. Epub 2012 Jul 3.
10
Disproportionality analysis for signal detection of implantable cardioverter-defibrillator-related adverse events in the Food and Drug Administration Medical Device Reporting System.
Pharmacoepidemiol Drug Saf. 2012 Jan;21(1):87-93. doi: 10.1002/pds.2261. Epub 2011 Nov 18.
Zotero 插件